Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 3,902,667 | reported | 02 Mar 2026 | tx 98+8,425,460−16,021,629 |
| Sionna Therapeutics, Inc. | 686,567 | reported | 21 Oct 2025 | tx 59+3,713,979−6,008,085 |
| Cogent Biosciences, Inc. | 61,338 | reported | 01 Jul 2020 | tx 16+3,627,660−3,267,483 |
| Dianthus Therapeutics, Inc. /DE/ | 20,000 | reported | 28 Jun 2022 | tx 11+6,085,685−13,006,580 |
| Tectonic Therapeutic, Inc. | 17,643 | reported | 06 Jun 2023 | tx 13+5,661,001−19,653,771 |
| Viridian Therapeutics, Inc.\DE | 12,000 | reported | 27 Jun 2018 | tx 5+586,489 |
| Larimar Therapeutics, Inc. | 8,509 | reported | 03 Jan 2018 | tx 15+5,697,040−35,373,545 |
| Vigil Neuroscience, Inc. | 0 | reported | 05 Aug 2025 | tx 31+4,587,317−16,732,856 |
3 purchases reported after at least 12 months of silence — most recent on 10 Feb 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 10,052 | 90.13 USD | |
| 02 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 71,814 | 90.13 USD | |
| 11 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 5,125 | 91.23 USD | |
| 11 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 976 | 91.23 USD | |
| 12 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 570 | 91.04 USD | |
| 12 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 108 | 91.04 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 31,459 | 88.64 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 17,825 | 89.25 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 16,338 | 93.20 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 47,349 | 92.41 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 85,862 | 93.20 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 5,979 | 88.64 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 3,391 | 89.25 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 2,001 | 90.14 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 9,060 | 92.41 USD | |
| 10 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 10,545 | 90.14 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 83 | 36.42 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 17 | 36.42 USD | anomaly |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 5,316 | 35.69 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 25,327 | 35.69 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 1,210 | 34.91 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 5,763 | 34.91 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 4,187 | 33.87 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 19,948 | 33.87 USD | |
| 21 Oct 2025 | SALE | Sionna Therapeutics, Inc. | 4,688 | 32.69 USD |